Psychiatrists say fentanyl test strips can be powerful tool for slowing the scourge of overdoses attributed to tainted street drugs.Read More
Here’s how our Neurological Institute is working to counter national trends of burnout and leadership inequity among women in medicine, with a focus on the role psychologists can play in such efforts.
A neurosurgeon deeply involved with the Brain Trauma Foundation’s guidelines for head injuries shares insights on the essentials of management and what research in the field is focusing on.
While recognition of autoimmune encephalitis has increased substantially, autoimmune causality is still overlooked for many subtle neurologic abnormalities. A subspecialist provides an update on autoimmune neurology.
A screening blood test could accelerate drug development and enable earlier, more effective intervention. We offer an overview of promising efforts in pursuit of a reliable blood-based biomarker.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Multimodal monitoring has reached the point where standards and guidelines are starting to be developed. A leading neurointensivist explains what this approach involves and where it’s likely headed.
Only about 10% of candidates for surgical intervention for movement disorders end up undergoing surgery. Our latest podcast discusses new approaches that may increase that percentage.
A medical spine specialist explains why frailty looms especially large in patients with spine disease, why it doesn’t necessarily go hand in hand with age, and proactive ways to reduce it in this population.
Traditional means of monitoring patients with MS are increasingly inadequate. The director of our MS program discusses emerging technologies and research studies to explore their roles.
Monthly or quarterly dosing and favorable side-effect profiles make these new medications a welcome addition to the armamentarium for migraine prevention. We share insights on how they fit into practice.
The neurologic effects of COVID-19 continue to expand and are as varied as the mechanisms behind them. Dr. Jeffrey Cohen discusses our latest understanding of these neurologic manifestations and some ongoing related research.